<< Back to Investments

HempMeds Brasil™

HempMeds® Brasil is a corporate affiliated company of Medical Marijuana, Inc. (OTC Pink:MJNA) and an exclusive distributor of RSHO™ to Brazil. HempMeds® Brasil offers specialized marketing, sales, customer service, and logistics to supply natural hemp oil rich in CBD to the families of Brazil. HempMeds® Brasil’s flagship product, RSHO™ became the first hemp oil product containing CBD to be legally imported into the country of Brazil, after a family won a court battle to legally use the product for their daughter with a form of intractable epilepsy known as CDLK5. Shortly after, Brasil’s governing agency approved HempMeds Brasil’s RSHO™ product for all Brazilians with qualifying conditions, to import the product. With a population of approximately 200 million, Brazil represents a significant market as well as a distribution gateway throughout South America.

Connect


550 West C Street, Suite 2040
San Diego, California 92101
United States of America
21 4063 9179
Contact
www.hempmeds.com.br

October 25, 2017

Medical Marijuana, Inc. Subsidiary HempMeds® Brazil Announces Prominent Coverage in Brazilian Newspapers After Legal Victory

Federal Judge in Brazil Orders the Government to Subsidize Payments for Real Scientific Hemp Oil™ (RSHO™) for Brazilian Citizen SAN DIEGO, Oct. 24, 2017 — Medical Marijuana, Inc.(OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today subsidiary HempMeds®

October 2, 2017

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Applauds Establishment of Patient Association in Brazil to Provide Cannabis Patients Greater Access

SAN DIEGO, Oct. 2, 2017 /PRNewswire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil is excited to support the establishment of the Associação Nacional dos usuários de Canabidiol (ANUC) Patient Association in Brazil dedicated to

September 26, 2017

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil To Sponsor 8th ABN-RJ/ANERJ Congress in Rio de Janeiro

SAN DIEGO, Sept. 26, 2017 — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil is proud to sponsor the 8th Brazilian Academy of Neurology/Association of Neurology of

August 23, 2017

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil’s Sold-Out Doctor Symposium on Medical Cannabis Garners Vast Media Coverage Across Brazil

SAN DIEGO, Aug. 23, 2017 /PRNewswire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil held a successful, sold-out Doctor Symposium in Sao Paulo, Brazil on August 15, with 50 doctors in attendance, which garnered vast media

August 14, 2017

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil To Hold Its Second Doctor Symposium on Medical Cannabis in Sao Paulo, Brazil

SAN DIEGO, Aug. 14, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil is holding a sold-out doctor symposium in Sao Paulo, Brazil, dedicated to providing the Brazilian medical community with information about the

July 19, 2017

Amyotrophic Lateral Sclerosis (ALS) and Psoriasis Patients Receive Brazilian Government Permission to Be Treated with Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil, Flagship Product RSHO™

SAN DIEGO, July 19, 2017 /PRNewswire/ — Medical Marijuana, Inc. (MJNA) is the first publicly traded cannabis company in the United States. Its subsidiary HempMeds® Brasil today announced that the Company’s hemp cannabidiol (CBD) oil product Real Scientific Hemp Oil™ [RSHO™] has been prescribed by doctors in the country for the treatment

March 30, 2017

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil To Hold Country’s First-Ever Symposium On Medical Cannabis For Health Professionals

Company to Educate Brazilian Medical Community on Therapeutic Uses of Cannabis, Importation Rules to Provide Patients Greater Access SAN DIEGO, March 30, 2017 — Medical Marijuana, Inc. ( MJNA ), the first publicly traded cannabis company in the United States, today

March 1, 2017

Medical Marijuana, Inc. Clarifies Operations Unaffected by White House Statements Hinting at Recreational Marijuana Crackdown

SAN DIEGO, March 1, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, is reassuring customers, shareholders, and the public that the company’s operations in the federally legal hemp cannabidiol (CBD) market are unaffected by

March 1, 2017

Autism Approval: Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Receives Brazilian Government Permission for Import of Flagship Product RSHO™

SAN DIEGO, Feb. 28, 2017 — Medical Marijuana, Inc. (OTC PINK:MJNA), the first publicly traded cannabis company in the United States, subsidiary HempMeds® Brasil today announced that the Brazilian government approved a prescription for the Company’s cannabidiol (CBD) oil product Real

February 23, 2017

Multiple Sclerosis Approval: Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Receives Brazilian Government Permission for Import of Flagship Product RSHO™

SAN DIEGO, Feb. 21, 2017 — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, subsidiary, HempMeds® Brasil today announced that the Brazilian government has authorized a doctor’s prescription for the Company’s hemp cannabidiol (CBD) oil product

February 15, 2017

Medical Marijuana, Inc. Subsidiary, HempMeds Brasil Featured in ‘Veja’ Article Highlighting Brazilian Health Authority Approval of RSHO™ on Patients with Alzheimer’s Disease

Article details the groundbreaking decision and possible implications for Alzheimer’s patients SAN DIEGO, Feb. 15, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded Cannabis Company in the United States, subsidiary HempMeds® Brasil was featured in a Veja.com

February 7, 2017

Alzheimer’s Patient Receives Brazilian Government Permission to be Treated with Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil, Flagship Product RSHO™

National Health Surveillance Agency ANVISA Authorizes Doctor’s Prescription for RSHO™ to Treat Patient Suffering from Effects of Alzheimer’s Disease SAN DIEGO, Feb. 7, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first publicly traded cannabis company in the United States,

February 2, 2017

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches New Website

SAN DIEGO, Feb. 2, 2017 — Medical Marijuana, Inc. (OTC PINK:MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds Brasil™ has launched a new website featuring brand information, a navigable web interface layout,

February 1, 2017

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Begins Importation of RSHO™ Green Label Into Brazil

AN DIEGO, Feb. 1, 2017  — Medical Marijuana, Inc. (otc pink:MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds® Brasil has begun the process of importing its Real Scientific Hemp Oil™ (RSHO) Green

January 5, 2017

Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil Announces Groundbreaking Distribution Partnership with Paragon HealthCare BR

Partnership to Provide Expanded Accessibility to RSHO(TM), the First-Ever Product Approved for Import by Brazilian Government SAN DIEGO, CA — (Marketwired) — 01/05/17 — Medical Marijuana, Inc.(OTC PINK:MJNA), the first-ever publicly traded cannabis company in the United States, has announced

December 29, 2016

Medical Marijuana, Inc. Featured in L.A. Weekly Profile Story Covering Historic Export Agreements With Mexico, Other Latin American Nations

Article Features Unique Nature of Export Agreement of Cannabis-Related Products From Southern California to Latin America SAN DIEGO, CA — (Marketwired) — 12/29/16 — Medical Marijuana, Inc.(OTC PINK:MJNA), the first-ever publicly traded cannabis company in the United States, today announced

December 22, 2016

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Begins Importation of Real Scientific Hemp Oil-X™ Product Line Into Brazil

SAN DIEGO, CA–(Marketwired – December 21, 2016) – Medical Marijuana, Inc. (otc pink:MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Real Scientific Hemp Oil-X™ (RSHO-X™) product line is now being imported into Brazil

December 14, 2015

Medical Marijuana, Inc.’s HempMeds Brasil™ Now Has Three Medical Indications Approved As Prescriptions – 100% of the Costs Now Covered by Brazilian Government

Medical Marijuana, Inc.’s Hemp-Based Cannabidiol (CBD) Oil Products Cost Being 100% Subsidized by the Brazilian Government for Three Indications: Epilepsy, Parkinson’s and Chronic Pain San Diego, Calif. — December 14, 2015 – Medical Marijuana, Inc.’s (OTC Pink: MJNA) cannabidiol (CBD)

December 8, 2015

Chronic Pain: Third Indication Approved by Brazilian Government for Medical Marijuana Inc.’s Real Scientific Hemp Oil™ (RSHO™)

MJNA’s Hemp Cannabidiol (CBD) Oil Products Are Shipping to Residents of Brazil With Proper Importation Documentation San Diego, Calif. — December 8, 2015 — Medical Marijuana, Inc. (OTC Pink: MJNA) is pleased to announce to the public and its shareholders

November 23, 2015

Medical Marijuana Inc.’s New Real Scientific Hemp Oil™ Liquid Product Line Now Available for Import Into Brazilian Market

New RSHO™ Product Line Includes All-Natural Non-GMO Hemp Oil with MCT Oil San Diego, California — November 23, 2015 — Medical Marijuana, Inc. (OTC Pink: MJNA) is pleased to announce the immediate release of its new line of Real Scientific